Randomized Trial on the Effect of an Oral Spleen Tyrosine Kinase Inhibitor in the Treatment of IgA Nephropathy

Authors: Tam, Frederick W.K., Tumlin, James, Barratt, Jonathan, Rovin, Brad H., Roberts, Ian S.D., Roufosse, Candice, Cook, H. Terence, Bhangal, Gurjeet, Brown, Alison L., Busch, Martin, Dudhiya, Fayaz, Duliege, Anne-Marie, Fraser, Donald J., Gale, Daniel P., Huang, Chiu-Ching, Lai, Ping-Chin, Lee, Meng, Masuda, Esteban S., McAdoo, Stephen P., Rosenkranz, Alexander R., Sommerer, Claudia, Sunder-Plassmann, Gere, Szeto, Cheuk-Chun, Tang, Sydney C.W., Williamson, Don E., Willcocks, Lisa, Vielhauer, Volker, Kim, Min Jeong, Todd, Leslie, Zayed, Hany, Tong-Starksen, Sandra, Lafayette, Richard

Source: In Kidney International Reports December 2023 8(12):2546-2556

CSF1 receptor inhibition of tenosynovial giant cell tumor using novel disease-specific MRI measures of tumor burden

Authors: Peterfy, Charles, Chen, Yan, Countryman, Peter, Chmielowski, Bartosz, Anthony, Stephen P, Healey, John H, Wainberg, Zev A, Cohn, Allen L, Shapiro, Geoffrey I, Keedy, Vicki L, Singh, Arun, Puzanov, Igor, Wagner, Andrew J, Qian, Meng, Sterba, Mike, Hsu, Henry H, Tong-Starksen, Sandra, Tap, William D

Source: Future oncology. 18(12):1449-1459

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100187735278.0x000001&indx=1&recIds=ETOCvdc_100187735278.0x000001

Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial

Authors: Tap, William D, Gelderblom, Hans, Palmerini, Emanuela, Desai, Jayesh, Bauer, Sebastian, Blay, Jean-Yves, Alcindor, Thierry, Ganjoo, Kristen, Martín-Broto, Javier, Ryan, Christopher W, Thomas, David M, Peterfy, Charles, Healey, John H, van de Sande, Michiel, Gelhorn, Heather L, Shuster, Dale E, Wang, Qiang, Yver, Antoine, Hsu, Henry H, Lin, Paul S, Tong-Starksen, Sandra, Stacchiotti, Silvia, Wagner, Andrew J

Source: In The Lancet 10-16 August 2019 394(10197):478-487

Human Immunodeficiency Virus Long Terminal Repeat Responds to T-Cell Activation Signals

Authors: Tong-Starksen, Sandra E., Luciw, Paul A., Peterlin, B. Matija

Source: Proceedings of the National Academy of Sciences of the United States of America, 1987 Oct 01. 84(19), 6845-6849.

Access URL: https://www.jstor.org/stable/30677

Interactions between Tat of HIV-2 and transcription factor Sp1.

Authors: Pagtakhan, A. Santos, Tong-Starksen, Sandra E.

Source: Virology; November 24 1997, Vol. 238, p221-230, 10p

Second exon of Tat of HIV-2 is required for optimal trans-activation of HIV-1 and HIV-2 LTRs.

Authors: Tong-Starksen, Sandra E., Baur, Andreas, Lu, Xiao-bin

Source: Virology; August 1993, Vol. 195, p826-830, 5p

This result is not displayed to guests.
Login for full access.